Literature DB >> 18762351

Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer.

Toshio Sugane1, Masayuki Baba, Reiko Imai, Mio Nakajima, Naoyoshi Yamamoto, Tadaaki Miyamoto, Hidefumi Ezawa, Kyousan Yoshikawa, Susumu Kandatsu, Tadashi Kamada, Junetsu Mizoe, Hirohiko Tsujii.   

Abstract

Surgical resection is the standard treatment for stage I non-small cell lung cancer (NSCLC). However, elderly patients with NSCLC often suffer from other conditions, such as chronic obstructive pulmonary disease (COPD) or cardiovascular disease, and are not suitable candidates for surgery. Different modalities to treat stage I NSCLC have been developed, such as stereotactic radiotherapy (SRT), proton beam radiotherapy and carbon ion radiotherapy (CIRT). Between April 1999 and November 2003, we treated 129 patients with stage I NSCLC using CIRT. In this study, we focused on 28 patients aged 80 years and older who underwent CIRT, and analyzed the effectiveness of CIRT in treating their lung cancer and the impact on their activity of daily life (ADL). The 5-year local control rate for these patients was 95.8%, and the 5-year overall survival rate was 30.7%, but there were no patients who started home oxygen therapy or had decreased ADL. Our data demonstrate that CIRT was effective in treating elderly patients with stage I NSCLC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18762351     DOI: 10.1016/j.lungcan.2008.07.007

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  15 in total

Review 1.  Charged particles in radiation oncology.

Authors:  Marco Durante; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2009-12-01       Impact factor: 66.675

2.  [11C]Gefitinib ([11c]Iressa): radiosynthesis, in vitro uptake, and in vivo imaging of intact murine fibrosarcoma.

Authors:  Ming-Rong Zhang; Katsushi Kumata; Akiko Hatori; Nobuhiko Takai; Jun Toyohara; Tomoteru Yamasaki; Kazuhiko Yanamoto; Joji Yui; Kazunori Kawamura; Sachiko Koike; Koichi Ando; Kazutoshi Suzuki
Journal:  Mol Imaging Biol       Date:  2009-09-26       Impact factor: 3.488

Review 3.  Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review.

Authors:  Madelon Pijls-Johannesma; Janneke P C Grutters; Frank Verhaegen; Philippe Lambin; Dirk De Ruysscher
Journal:  Oncologist       Date:  2010-01-12

4.  Carbon-ion radiotherapy for octogenarians with locally advanced non-small-cell lung cancer.

Authors:  Kazuhiko Hayashi; Naoyoshi Yamamoto; Mio Nakajima; Akihiro Nomoto; Hitoshi Ishikawa; Kazuhiko Ogawa; Hiroshi Tsuji
Journal:  Jpn J Radiol       Date:  2021-02-19       Impact factor: 2.374

5.  Radiosensitizing effect of carboplatin and paclitaxel to carbon-ion beam irradiation in the non-small-cell lung cancer cell line H460.

Authors:  Nobuteru Kubo; Shin-ei Noda; Akihisa Takahashi; Yukari Yoshida; Takahiro Oike; Kazutoshi Murata; Atsushi Musha; Yoshiyuki Suzuki; Tatsuya Ohno; Takeo Takahashi; Takashi Nakano
Journal:  J Radiat Res       Date:  2015-01-18       Impact factor: 2.724

6.  Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study.

Authors:  Nathan A Cannon; Puneeth Iyengar; Hak Choy; Robert Timmerman; Jeffrey Meyer
Journal:  BMC Cancer       Date:  2014-12-17       Impact factor: 4.430

Review 7.  Carbon ion therapy for early-stage non-small-cell lung cancer.

Authors:  Yusuke Demizu; Osamu Fujii; Hiromitsu Iwata; Nobukazu Fuwa
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

Review 8.  Particle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literature.

Authors:  Krista C J Wink; Erik Roelofs; Timothy Solberg; Liyong Lin; Charles B Simone; Annika Jakobi; Christian Richter; Philippe Lambin; Esther G C Troost
Journal:  Front Oncol       Date:  2014-10-29       Impact factor: 6.244

9.  Dosimetric comparison of carbon ion and X-ray radiotherapy for Stage IIIA non-small cell lung cancer.

Authors:  Nobuteru Kubo; Jun-Ichi Saitoh; Hirofumi Shimada; Katsuyuki Shirai; Hidemasa Kawamura; Tatsuya Ohno; Takashi Nakano
Journal:  J Radiat Res       Date:  2016-05-29       Impact factor: 2.724

10.  Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.

Authors:  Mio Nakajima; Naoyoshi Yamamoto; Kazuhiko Hayashi; Masataka Karube; Daniel K Ebner; Wataru Takahashi; Makoto Anzai; Kenji Tsushima; Yuji Tada; Koichiro Tatsumi; Tadaaiki Miyamoto; Hiroshi Tsuji; Takehiko Fujisawa; Tadashi Kamada
Journal:  Radiat Oncol       Date:  2017-09-02       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.